Sort   by:  
 Page size 
UnknownSIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis.
Not available
S-EPMC6553796 | biostudies-literature
UnknownEffect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.
Not available
S-EPMC4979167 | biostudies-literature
UnknownAn observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol.
Not available
S-EPMC11332920 | biostudies-literature
UnknownA phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia.
Not available
S-EPMC4643417 | biostudies-literature
UnknownThe diverse genetic origins of a Classical period Greek army.
Not available
S-EPMC9564095 | biostudies-literature
UnknownFrequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.
Not available
S-EPMC5714507 | biostudies-literature
UnknownStenting versus aggressive medical therapy for intracranial arterial stenosis.
Not available
S-EPMC3552515 | biostudies-literature
UnknownAggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Not available
S-EPMC3971471 | biostudies-literature
Sort   by:  
 Page size